TP53 and cancer: Genome-wide mapping of genetic interactions in human cancer cells has become possible with the development of large-scale RNA interference (RNAi) libraries and focused efforts have been made to systematically identify negative genetic interactions in paired isogenic cancer cell lines, for example, with mutant RAS (Luo et al, 2009a) and loss of TP53 (Krastev et al, 2011).